Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, diarrhoea on Mounjaro does ease as the body adjusts to treatment. Clinical trial data and NHS guidance both show that loose stools and related gut symptoms are most pronounced in the first few weeks after starting or after a dose increase, then typically settle. That pattern holds across the majority of participants. These are prescription-only medicines, and a clinician reviews your suitability before anything is prescribed — including discussing how to manage side effects if they arise. If you want a fuller picture of what the trial evidence actually shows, and when diarrhoea should prompt a call to your care team, the detail is below.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity over 72 weeks and recorded gastrointestinal events systematically throughout. Diarrhoea was among the most frequently reported side effects in participants taking tirzepatide, particularly at higher doses. Crucially, the data showed that GI events were concentrated in the early weeks of each dose period, rates fell noticeably once the body had time to adapt. That is the evidence behind the widely given clinical advice: the gut usually catches up.
The NHS tirzepatide medicines page reflects this, describing diarrhoea as a common side effect and noting that symptoms affecting the gut tend to be temporary. Temporary does not mean trivial, though. For some people the first week at a new dose is genuinely disruptive, and that deserves honest acknowledgement rather than a breezy reassurance.
The reason Mounjaro affects the gut at all is rooted in its dual mechanism, it acts on both GIP and GLP-1 receptors, slowing the movement of food through the digestive tract in ways the body has not encountered before. The early GI effects are essentially the gut recalibrating. For a closer look at the underlying biology, our page on why Mounjaro causes diarrhoea covers the mechanism in detail.
Most clinicians and the trial evidence point to the same rough pattern: diarrhoea is most likely in the first one to two weeks after starting Mounjaro or moving to a higher dose. For many people it resolves within that window, though for a smaller group it lingers a little longer at each step up the dose ladder.
Practical steps that can ease things along: eating smaller, lower-fat meals reduces the workload on a digestive system that is already slowing down; keeping fluid intake up matters more than it might seem on an ordinary day; and spacing meals out rather than eating two large ones tends to help. None of this replaces your prescriber's guidance or the Patient Information Leaflet, both of which should be your first reference for anything specific to your dose and circumstances.
Some people find the timing predictable enough to plan around, knowing that the day after a weekly injection is the most likely one for gut symptoms means they can avoid back-to-back commitments. It is the kind of practical knowledge that our prescribers discuss with patients as part of aftercare. If you are also wondering whether constipation on Mounjaro goes away, that symptom follows a similar adjustment pattern and is worth reading about alongside diarrhoea. If fatigue is also a concern alongside gut symptoms, the pattern for tiredness on Mounjaro follows a similar adjustment arc and is worth reading alongside this.
The adjustment pattern described above applies to mild-to-moderate, transient diarrhoea. There are circumstances where you should seek medical help promptly rather than waiting it out.
Contact your prescriber or GP, or go to urgent care, if you notice: diarrhoea that is severe or shows no sign of easing after a week or two; signs of dehydration such as dark urine, dizziness or a dry mouth; blood in your stool; or diarrhoea accompanied by severe stomach pain, particularly pain that is intense and reaches into the back. That last combination can be a sign of pancreatitis, a rare but serious reaction flagged in a January 2026 MHRA Drug Safety Update covering GLP-1 medicines. It is uncommon, but it should never be dismissed as ordinary stomach upset.
If you are losing a lot of fluid and struggling to keep anything down, dehydration can affect kidney function more quickly than people expect. This is particularly relevant for anyone already on blood pressure medication or other medicines that interact with kidney function, flag it early. You can report any suspected side effect directly to the MHRA through the Yellow Card scheme, which helps regulators track real-world safety signals across the population.
For a fuller overview of which Mounjaro side effects resolve with time and which need review, this page on which Mounjaro side effects go away covers the broader picture across GI, fatigue and other common reactions.
Knowing a side effect is common is only part of what you need. Knowing what to do about it, and when to escalate, is the more useful half. At nume, a GPhC-registered Independent Prescriber personally reviews every consultation, not software, not an automated queue. If diarrhoea or other gut symptoms are a concern, that conversation happens before anything is prescribed.
Every patient also has access to priority aftercare seven days a week, so if symptoms are worse than expected after starting or stepping up a dose, there is someone to contact, not just a leaflet. Our full side effects guide covers the complete picture if you want to read around the topic before consulting, and our Mounjaro overview is a good starting point if you are still weighing up whether the treatment is right for you.
If you are ready to discuss suitability with a prescriber, start your free consultation, side effects, your health history and what to expect are all part of that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.